Ask AI
ProCE Banner Activity

Expert Insights in Hidradenitis Suppurativa: Answers to Your Most Asked Questions

Clinical Thought

Gain expert insights on diagnosing and assessing patients with hidradenitis suppurativa (HS), planning treatment for those with certain comorbidities, and employing the latest HS therapies to improve outcomes.

Released: April 24, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with the HS Foundation

ProCE Banner

Supporters

Supported by educational grants from Incyte Corporation, Novartis Pharmaceuticals Corporation, and UCB Inc.

Incyte Corporation

Novartis Pharmaceuticals Corporation

UCB Inc.

Partners

HS Foundation

ProCE Banner

Target Audience

This activity is intended for dermatologists, dermatology residents and fellows, nurse practitioners, and physician associates and other HCPs who care for patients with hidradenitis suppurativa.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply consensus-driven diagnostic strategies to enhance the accuracy and timeliness of HS diagnosis

  • Formulate comprehensive care plans that consider quality of life and comorbidities for patients with hidradenitis suppurativa, including those with skin of color.”

Disclosure

Primary Author

Mikael Horissian, MD, MBA: consultant/advisor/speaker: Incyte, Regeneron, UCB.

Venessa Peña-Robichaux, MD: advisor: Osquo.